Skip to main content
logo
Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.300
+0.030 (2.36%)
At close: Jun 26, 2026, 4:00 PM EDT
1.327
+0.027 (2.07%)
After-hours: Jun 26, 2026, 7:58 PM EDT

Allarity Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.32----
Gross Profit
-0.32----
Selling, General & Admin
6.116.3211.4410.039.9612.36
Research & Development
6.56.66.17.16.9314.2
Other Operating Expenses
--9.7-17.57-
Total Operating Expenses
12.612.9327.2417.1334.4626.56
Operating Income
-12.6-12.61-27.24-17.13-34.46-26.56
Interest Income
0.740.80.530.021.812.35
Interest Expense
-0.3-0.19-0.65-0.5-0.22-0.5
Other Non-Operating Income (Expense)
1.632.134.8111.132.180.92
Total Non-Operating Income (Expense)
2.082.754.6910.6233.772.78
Pretax Income
-8.5-11.23-24.9-11.82-17.58-26.52
Provision for Income Taxes
--0.38-0.08-1.52-0.13
Net Income
-11.25-11.23-24.52-11.9-16.06-26.65
Net Income Attributable to Preferred Dividends
---0.64-8.52-4.99-
Net Income to Common
-8.5-11.23-25.15-20.42-21.05-26.65
Shares Outstanding (Basic)
16142000
Shares Outstanding (Diluted)
16142000
Shares Change (YoY)
254.45%794.77%47373.85%497.35%87.14%7691.05%
EPS (Basic)
-0.72-0.78-15.65-6031.31-37121500.00-3520080.00
EPS (Diluted)
-0.72-0.78-15.65-6031.31-37121500.00-3520080.00
Free Cash Flow
-16.63-14.83-17.65-12.75-16.84-14.89
Free Cash Flow Per Share
-1.07-1.03-10.98-3765.14-29708.80-49159.50
Gross Margin
-100.00%----
Operating Margin
--3939.06%----
Profit Margin
--3509.69%----
FCF Margin
--4633.75%----
EBITDA
-12.65-12.62-27.23-17.09-34.4-26.45
EBITDA Margin
--3943.12%----
EBIT
-12.6-12.61-27.24-17.13-34.46-26.56
EBIT Margin
--3939.06%----
Effective Tax Rate
-0.00%-1.53%0.70%8.65%0.50%
SEC Filings: 10-K · 10-Q